Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05328778
PHASE4
Pharmacokinetics and Pharmacodynamics of Sugammadex Dosed by Corrected Body Weight for Reversal of Vecuronium in Obese Patients
Sponsor: Guangzhou General Hospital of Guangzhou Military Command
View on ClinicalTrials.gov
Summary
The purpose of this study is to illustrate pharmacokinetics of sugammadex in reversal of vecuronium-induced neuromuscular blockade in patients during laparoscopic surgery
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2022-04-14
Completion Date
2026-04-01
Last Updated
2026-09-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
Sugammadex
Each patient received a single dose administration of sugammadex 2mg/kg according to the ideal body weight (IBW) at reappearance of the second twitch of the train-of-four (TOF).
Locations (1)
Guangzhou Military Region General Hospital, Department of Anesthesiology
Guangzhou, Guangdong, China